WallStreetZenWallStreetZen

NASDAQ: MREO
Mereo Biopharma Group PLC Stock Ownership - Who owns Mereo Biopharma Group?

Insider buying vs selling

Have Mereo Biopharma Group PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MREO insiders and whales buy or sell their stock.

MREO Shareholders

What type of owners hold Mereo Biopharma Group PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Rubric Capital Management LP4.56%31,950,000$88.82MInsider
Rubric Capital Management LP1.93%13,552,997$37.68MInstitution
Soleus Capital Management LP1.39%9,777,419$27.18MInstitution
Mangrove Partners Im LLC1.25%8,752,893$24.33MInstitution
Rock Springs Capital Management LP1.14%7,983,851$22.20MInstitution
Suvretta Capital Management LLC1.05%7,370,838$20.49MInstitution
683 Capital Management LLC0.88%6,200,000$17.24MInstitution
Alkeon Capital Management LLC0.60%4,238,100$11.78MInstitution
Tejara Capital Ltd0.53%3,713,129$10.32MInstitution
Clearline Capital LP0.47%3,326,718$9.25MInstitution

1 of 3

MREO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MREO11.20%4.59%
REPL67.71%32.29%Net Selling
NGNE36.48%63.52%Net Buying
BMEA61.83%38.17%Net Selling
LXRX21.34%78.66%Net BuyingNet Buying

Mereo Biopharma Group Stock Ownership FAQ

Who owns Mereo Biopharma Group?

Mereo Biopharma Group (NASDAQ: MREO) is owned by 11.20% institutional shareholders, 4.59% Mereo Biopharma Group insiders, and 84.21% retail investors. Rubric Capital Management LP is the largest individual Mereo Biopharma Group shareholder, owning 31.95M shares representing 4.56% of the company. Rubric Capital Management LP's Mereo Biopharma Group shares are currently valued at $88.82M.

If you're new to stock investing, here's how to buy Mereo Biopharma Group stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.